Less Ads, More Data, More Tools Register for FREE

Pin to quick picks61ZU.L Regulatory News (61ZU)

  • There is currently no data for 61ZU

Directorate Change

21 Dec 2017 09:00

RNS Number : 0526A
Royal Bank of Scotland Group PLC
21 December 2017
 

21 December 2017

The Royal Bank of Scotland Group plc 

LEI: 2138005O9XJIJN4JPN90

Directorate Changes

The Royal Bank of Scotland Group plc ("RBS") announces today that with effect from 1 January 2018:-

· Sir Sandy Crombie will step down as a non-executive director of RBS, and as Senior Independent Director and Chairman of the Group Performance & Remuneration Committee;

· Robert Gillespie will assume the role of Chairman of the Group Performance & Remuneration Committee;

· Mark Seligman will assume the role of Senior Independent Director and will be appointed as a member of the Group Performance & Remuneration Committee; and

· Dr Lena Wilson, CBE will be appointed as a non-executive director of RBS.

Howard Davies, Chairman of RBS, said:

"Sandy Crombie has made an outstanding contribution to the Board of RBS and we have benefitted greatly from his wisdom and experience. The Board and I will miss Sandy's presence as a much valued colleague and friend, and he leaves RBS with our very best wishes for the future.

I am delighted that Robert Gillespie will be building on Sandy's excellent work as Chairman of the Group Performance & Remuneration Committee, and that Mark Seligman is assuming the pivotal role of Senior Independent Director. Robert and Mark are both ideally suited to these positions, and I know they will have much to contribute. Mark will also join the Group Performance & Remuneration Committee.

Finally, we are very pleased to welcome Dr Lena Wilson as a non-executive director. With her strong public sector and commercial background, I am confident that Lena's appointment will further strengthen the RBS Board's composition and we look forward to welcoming her to the Board."

Lena Wilson has been a non-executive director and member of the audit committee of Intertek Group plc since 2012.

There are no other matters requiring disclosure under Listing Rule 9.6.13.

For further information contact:

RBS Media Centre +44 131 523 4205

Notes to Editors

Biographical Details

Dr Lena Wilson, CBE

Lena Wilson was Chief Executive of Scottish Enterprise from November 2009 until October 2017, having previously held the roles of Chief Operating Officer, Chief Executive Officer, Scottish Development International (Scotland's international trade and investment arm) and Senior Director, Customer Relations. Prior to that, Lena was Senior Investment Advisor to The World Bank in Washington DC, advising developing countries on foreign direct investment and private sector development.  Lena has also served as a member of Scotland's Financial Services Advisory Board and as Chair of Scotland's Energy Jobs Taskforce.

Lena has been a non-executive director and member of the audit committee of Intertek Group plc since 2012 and was appointed as a non-executive director of Scottish Power Renewables Limited in November 2017. She is also an ambassador for The Prince & Princess of Wales Hospice (Glasgow) and the Edinburgh Military Tattoo, and served on the Board of the Prince's Scottish Youth Business Trust for 10 years. In June 2015, Dr Wilson received a CBE for her services to economic development in Scotland.

Robert Gillespie

Robert Gillespie joined the RBS Board in December 2013 and is a member of the Group Nominations & Governance Committee, Group Performance and Remuneration Committee, Sustainable Banking Committee and GRG Board Oversight Committee. He is also an independent board director at Ashurst LLP and Chairman of Council at the University of Durham. Robert began his career with Price Waterhouse where he qualified as a chartered accountant. He then moved into banking, joining SG Warburg and specialising in corporate finance, and was appointed as Co-Head and Managing Director of its US investment banking business in 1989. Following the acquisition in 1995 of Warburg by Swiss Bank Corporation (which subsequently merged with UBS), he then held various management roles before being appointed Vice Chairman of UBS Bank. Robert was also seconded to the UK Panel on Takeovers and Mergers as Director General, from 2010 to 2013.

Mark Seligman

Mark Seligman joined the RBS Board in April 2017 and is a member of the Group Nominations & Governance Committee. He has substantial FTSE 100 Board experience and is currently Senior Independent Director of Kingfisher plc, and a non-executive director of Smiths Group plc. Mark previously served as a non-executive Director of BG Group plc and as Deputy Chairman of G4S plc. During his executive career, Mark held various senior roles at Credit Suisse / BZW (including Deputy Chairman, CSFB Europe and Chairman, UK Investment Banking, CSFB); and previously SG Warburg (ultimately as Managing Director, Head of Advisory).  

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGIBDDSUDBGRB
Date   Source Headline
31st Jul 20203:54 pmRNSPublication of Supplementary Reg Doc & Prospectus
31st Jul 20207:00 amRNSInterim Results 2020
11th Jun 20205:15 pmRNSPublication of Supplementary Reg Doc & Prospectus
11th Jun 20208:00 amRNSRBS and NatWest Markets announce appointments
3rd Jun 202012:51 pmRNSPublication of Final Terms
27th May 20209:44 amRNSPublication of Final Terms
20th May 20206:27 pmRNSPublication of Final Terms
18th May 202011:24 amRNSPublication of Final Terms
15th May 20202:45 pmRNSPublication of Final Terms
14th May 20201:55 pmRNSPublication of Supplementary Prospectus
13th May 20202:14 pmRNSRegistration Document and Base Prospectus
1st May 20204:24 pmRNSPublication of Suppl.Prospcts
1st May 20207:02 amRNSQ1 Interim Management Statement
15th Apr 20202:35 pmRNSAmendment of Final Terms
14th Apr 20203:07 pmRNSPublication of Final Terms
9th Apr 20204:21 pmRNSPublication of Final Terms
7th Apr 20205:59 pmRNSPublication of Final Terms
3rd Apr 202011:14 amRNSPublication of Final Terms
1st Apr 202012:48 pmRNSPublication of Final Terms
26th Mar 202010:46 amRNSPublication of Final Terms
16th Mar 20205:14 pmRNSNatWest Markets N.V. 2019 ARA
16th Mar 20202:36 pmRNSPublication of Final Terms
24th Feb 20202:18 pmRNSPublication of Final Terms
17th Feb 20201:20 pmRNSPublication of Supplementary Prospectus
14th Feb 20207:03 amRNSAnnual Financial Report
14th Feb 20207:02 amRNSFinal Results
7th Jan 202011:09 amRNSPublication of Final Terms
27th Dec 201911:26 amRNSPublication of Final Terms
20th Dec 20197:00 amRNSPublication of Suppl.Prospcts
19th Dec 20197:00 amRNSNatWest Markets Change in Executive Directors
16th Dec 20194:42 pmRNSAmendments To Provisions Relating To Interest
6th Dec 20191:16 pmRNSPublication of Final Terms
4th Dec 20192:47 pmRNSPublication of Final Terms
2nd Dec 20193:00 pmRNSPublication of Suppl.Prospcts
29th Nov 20191:28 pmRNSAnnouncement of NatWest Markets N.V. Transfer
21st Nov 20196:29 pmRNSPublication of a Prospectus
19th Nov 20192:33 pmRNSPublication of Final Terms
4th Nov 201912:55 pmRNSPublication of Final Terms
25th Oct 20194:51 pmRNSPublication of Suppl.Prospcts
24th Oct 20197:01 amRNSQ3 Interim Management Statement
18th Oct 20192:50 pmRNSNotice of Redemption
4th Oct 20191:30 pmRNSPublication of Final Terms
13th Sep 20193:53 pmRNSPublication of Final Terms
28th Aug 20192:48 pmRNSPublication of Final Terms
2nd Aug 20192:47 pmRNSPublication of Supplementary Prospectus
2nd Aug 20197:01 amRNSInterim Results 2019
3rd Jul 20195:03 pmRNSPublication of Final Terms
2nd Jul 201912:02 pmRNSPublication of Supplementary Reg Doc & Prospectus
28th Jun 20192:45 pmRNSDividend Declaration
26th Jun 201912:32 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.